SCHEMBL18648483

SCHEMBL18648483

CCOC(=O)CCc1cc2c(cc1C)CCC(=O)N2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.43
▸ GAA P10253 1/20 0.43
▸ CYP4F2 P78329 2/20 0.42
▸ CYP4A11 Q02928 2/20 0.42
▸ HPGD P15428 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ DRD2 P14416 1/20 0.40
▸ CYP19A1 P11511 1/20 0.40
▸ CYP11B1 P15538 1/20 0.40
▸ CYP11B2 P19099 1/20 0.40
▸ MAPT P10636 2/20 0.39
▸ BRD4 O60885 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ AOC3 Q16853 1/20 0.37
▸ PDE3B Q13370 2/20 0.37
▸ PDE3A Q14432 2/20 0.37
▸ CRBN Q96SW2 2/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.36
▸ MAOA P21397 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1294840 0.88 ALDH1A1 (0.42) ALDH1A1GAACYP4F2CYP4A11HPGD
SCHEMBL18648565 0.84 NPSR1 (0.56) BRD4CRBNNPSR1MAOAMAOB
SCHEMBL11770569 0.77 MAOA (0.47) ALDH1A1MAPK1DRD2MAPTBRD4
SCHEMBL10646898 0.76 ALDH1A1 (0.54) ALDH1A1GAACYP4F2CYP4A11HSD17B10
SCHEMBL12110181 0.76 ALDH1A1 (0.35) ALDH1A1GAACYP4F2CYP4A11HPGD
SCHEMBL1026153 0.75 CRBN (0.45) ALDH1A1GAAHPGDMAPK1HSD17B10
SCHEMBL11289516 0.74 PDE3B (0.59) DRD2BRD4PDE3BPDE3AMAOA
SCHEMBL11603017 0.73 PDE3B (0.63) DRD2BRD4PDE3BPDE3AMAOA
SCHEMBL12559768 0.72 PKM (0.44) ALDH1A1BRD4MAOAMAOB
SCHEMBL12105471 0.72 ALDH1A1 (0.36) ALDH1A1GAACYP4F2CYP4A11HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9598434-B2 Benzazepine compound ASTELLAS PHARMA INC. (JP) 2017-03-21 — — US disclosed
Send feedback